Lifevantage director receives 17,888-share stock grant

The award vests in one installment on November 5, 2027, if the director remains in continuous service through that date.

Available on EDGAR 11/09/2026 - 05:00 PM EST Accepted by SEC EDGAR 11/09/2026 - 05:00 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Lifevantage Corp director Rajendran Anbalagan acquired 17,888 common shares on November 5, 2026, under the issuer’s outside director compensation program. The award will vest in a single installment on November 5, 2027, subject to his continuous service through that date. The reported $5.87 per-share figure equals the weighted average closing price over the ten trading days ending the day before the grant; it is not described as a purchase price. He directly held 41,887 common shares following the grant.

Insider Trade Summary

Grant/Award: 17,888 shares

Grant/Award 1 txn

Insider Anbalagan Rajendran

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock F1, F2	17,888	$5.87	$105K

Holdings After Transaction: Common Stock — 41,887 shares (Direct)

Footnotes (2)

1. F1. These shares were granted to the reporting person pursuant to the issuer's outside director compensation program and will vest in a single installment on November 5, 2027, subject to the reporting person's continuous service to the issuer through such date.
2. F2. The price reported in Column 4 is equal to the weighted average closing price of the issuer's common stock for the ten trading days ending the day before the date of the grant.

Key Figures

Awarded common shares: 17,888 shares Reported per-share price: $5.87 per share Direct common shares held following grant: 41,887 shares +1 more

4 metrics

Awarded common shares 17,888 shares Granted November 5, 2026

Reported per-share price $5.87 per share Equals the weighted average closing price over the ten trading days ending the day before the grant

Direct common shares held following grant 41,887 shares Following the November 5, 2026 grant

Vesting date November 5, 2027 One installment, subject to continuous service through that date

Key Terms

outside director compensation program, weighted average closing price, vest

3 terms

outside director compensation program financial

"pursuant to the issuer's outside director compensation program"

weighted average closing price financial

"equal to the weighted average closing price of the issuer's common stock"

vest financial

"will vest in a single installment"

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many shares did the LFVN director receive?

Rajendran Anbalagan was granted 17,888 common shares on November 5, 2026, under Lifevantage Corp’s outside director compensation program. The reported $5.87 per-share figure equals the weighted average closing price for the issuer’s common stock over the ten trading days ending the day before the grant.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Anbalagan Rajendran

(Last) (First) (Middle)

3300 TRIUMPH BLVD, SUITE 700

(Street)

LEHI UTAH 84043

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Lifevantage Corp [ LFVN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
11/05/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/05/2026		A		17,888(1)	A	$5.87(2)	41,887	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These shares were granted to the reporting person pursuant to the issuer's outside director compensation program and will vest in a single installment on November 5, 2027, subject to the reporting person's continuous service to the issuer through such date.

2. The price reported in Column 4 is equal to the weighted average closing price of the issuer's common stock for the ten trading days ending the day before the date of the grant.

	/s/ Rajendran Anbalagan	11/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)